Table 3 Characterization of DCX-loaded HA NCs and C12-HA NCs after purification by SEC.

From: Self-assembled hyaluronan nanocapsules for the intracellular delivery of anticancer drugs

Formulation

Size (nm)

PDI

ZP (mV)

EE%

Yield %

HA NCs

140 ± 5

0.2

−18 ± 2

88 ± 9

93 ± 2

C12-HA NCs

145 ± 6

0.2

−20 ± 1

86 ± 3

88 ± 8

Back to article page